Zobrazeno 1 - 4
of 4
pro vyhledávání: '"F P, Uhl"'
Autor:
Lion F. K. Uhl, Han Cai, Sophia L. Oram, Jagdish N. Mahale, Andrew J. MacLean, Julie M. Mazet, Theo Piccirilli, Alexander J. He, Doreen Lau, Tim Elliott, Audrey Gerard
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Effective responses to intracellular pathogens are characterized by T cell clones with a broad affinity range for their cognate peptide and diverse functional phenotypes. How T cell clones are selected throughout the response to retain a bre
Externí odkaz:
https://doaj.org/article/93ce11988e134251aa03f8a54f6cf7df
Autor:
Lion F. K. Uhl, Audrey Gérard
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8, p 2674 (2020)
T cells are essential mediators of the adaptive immune system, which constantly patrol the body in search for invading pathogens. During an infection, T cells that recognise the pathogen are recruited, expand and differentiate into subtypes tailored
Externí odkaz:
https://doaj.org/article/c1134acb1cd04fa9a3a2a81a6d070501
Autor:
K E Harfeldt, C Isaacson, P H Ehrlich, J C Justice, L Ostberg, Z A Moustafa, I K Gadi, F P Uhl, L J Sciorra
Publikováno v:
Clinical Chemistry. 34:1681-1688
Human monoclonal antibodies, owing to their decreased immunogenicity, are expected to be an improvement over mouse monoclonal antibodies for in vivo therapy. Human and primate monoclonal antibodies are best produced with a human x mouse heteromyeloma
Autor:
P H, Ehrlich, Z A, Moustafa, J C, Justice, K E, Harfeldt, I K, Gadi, L J, Sciorra, F P, Uhl, C, Isaacson, L, Ostberg
Publikováno v:
Clinical chemistry. 34(9)
Human monoclonal antibodies, owing to their decreased immunogenicity, are expected to be an improvement over mouse monoclonal antibodies for in vivo therapy. Human and primate monoclonal antibodies are best produced with a human x mouse heteromyeloma